Predictive Oncology - 15 Year Stock Price History | POAI
Historical daily share price chart and data for Predictive Oncology since 2010 adjusted for splits and dividends. The latest closing stock price for Predictive Oncology as of April 24, 2025 is 1.09.
- The all-time high Predictive Oncology stock closing price was 262500.00 on July 11, 2011.
- The Predictive Oncology 52-week high stock price is 3.06, which is 180.7% above the current share price.
- The Predictive Oncology 52-week low stock price is 0.55, which is 49.5% below the current share price.
- The average Predictive Oncology stock price for the last 52 weeks is 1.10.
| Predictive Oncology Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.3000 | 0.9200 | 1.9500 | 0.8680 | 1.0900 | 32.93% |
| 2024 | 1.5439 | 3.5250 | 3.6701 | 0.5501 | 0.8200 | -75.08% |
| 2023 | 5.0178 | 6.3200 | 12.1400 | 2.5900 | 3.2900 | -46.42% |
| 2022 | 10.9669 | 19.7600 | 21.6000 | 4.8600 | 6.1400 | -67.75% |
| 2021 | 23.7090 | 14.4000 | 44.0000 | 14.4000 | 19.0400 | 30.05% |
| 2020 | 29.1921 | 50.5800 | 69.6000 | 13.2000 | 14.6400 | -71.95% |
| 2019 | 125.0307 | 130.0000 | 219.0000 | 52.2000 | 52.2000 | -57.84% |
| 2018 | 204.4247 | 194.2000 | 278.0000 | 122.6000 | 123.8000 | -38.71% |
| 2017 | 352.6717 | 536.0000 | 616.0000 | 202.0000 | 202.0000 | -63.93% |
| 2016 | 2945.2897 | 15100.0000 | 18965.0000 | 314.0000 | 560.0000 | -96.19% |
| 2015 | 19930.2976 | 30000.0000 | 35550.0000 | 12000.0000 | 14700.0000 | -54.77% |
| 2014 | 58327.1825 | 103125.0000 | 103125.0000 | 20000.0000 | 32500.0000 | -67.90% |
| 2013 | 74465.7738 | 45000.0000 | 157500.0000 | 19125.0000 | 101250.0000 | 125.00% |
| 2012 | 38092.5000 | 105000.0000 | 123750.0000 | 11250.0000 | 45000.0000 | -57.14% |
| 2011 | 77248.5119 | 41250.0000 | 262500.0000 | 18750.0000 | 105000.0000 | 154.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.008B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |